Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study

por Takahashi, María Denise, Chouela, Edgardo Néstor, Dorantes, Gladys Leon, Roselino, Ana Maria, Santamaria, Jesùs, Allevato, Miguel Angel, Cestari, Tania, de Aillaud, Maria Eugenia Manzanera, Stengel, Fernando Miguel, Licu, Daiana
Publicado 2010

Control of Moderate-to-Severe Plaque Psoriasis with Efalizumab: 24-Week, Open-Label, Phase IIIb/IV Latin American Study Results

por Stengel, Fernando M, Petri, Valeria, Campbell, Gladys AM, Dorantes, Gladys Leon, López, Magdalina, Galimberti, Ricardo L, Valdez, Raúl P, de Arruda, Lucia F, Guerra, Mario Amaya, Chouela, Edgardo N, Licu, Daiana
Publicado 2009

Clinical Goals and Barriers to Effective Psoriasis Care

por Strober, Bruce E., van der Walt, Joelle M., Armstrong, April W., Bourcier, Marc, Carvalho, Andre V. E., Chouela, Edgardo, Cohen, Arnon D., de la Cruz, Claudia, Ellis, Charles N., Finlay, Andrew Y., Gottlieb, Alice B., Gudjonsson, Johann E., Iversen, Lars, Kleyn, C. Elise, Leonardi, Craig L., Lynde, Charles W., Ryan, Caitriona, Theng, Colin T., Valenzuela, Fernando, Vender, Ronald, Wu, Jashin J., Young, Helen S., Kimball, Alexa B.
Publicado 2018